Picture of BioNano Genomics logo

BNGO BioNano Genomics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for BioNano Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
R2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-23.4-18.5-29.8-41.1-72.4
Depreciation
Deferred Taxes
Non-Cash Items0.958-0.3994.134.7510.6
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.085-2.37-4.97-3.44-7.65
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-20.8-19.9-29.5-38.3-71.9
Capital Expenditures-1.02-0.332-0.0610-0.822
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.45-277
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1.02-0.332-0.061-2.45-278
Financing Cash Flow Items0.142-2-1.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities17.635.830.461.9336
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4.2315.50.78921.1-13.9

Or unlock with your email

Or unlock with your email